Tender Details
Description / Scope of Work
The National Institutes of Health (NIH), Islamabad invites bids for the extension of vaccine filling and supply line facility at the Biological Production Division (BPD) on a Design and Build model. This non-consultancy services tender is national in scope and follows a single-stage, two-envelope bidding process. The project involves design, construction, and supply of specialized equipment and infrastructure for vaccine production and filling operations at the BPD facility located in Islamabad, Federal Pakistan. The facility extension is critical to enhancing NIH's capacity for vaccine manufacturing and distribution to meet national immunization programme requirements.
Bidders must meet specified eligibility criteria including relevant technical qualifications, financial standing, and past experience with similar pharmaceutical or vaccine facility projects. A bid security declaration is required from all participants. Bidders should possess relevant registration with appropriate authorities and demonstrate capability to execute design-build contracts for pharmaceutical manufacturing facilities. All submissions must comply with the integrity pact provisions outlined in the tender documents.
The complete bidding documents are available from the NIH Procurement Office at Park Road, Islamabad. Bids must be submitted in two envelopes containing technical and financial proposals as per the bid data sheet instructions. The bid opening and evaluation will proceed according to the timeline specified in the tender notice. For further information, interested bidders should contact the Assistant Director, NIH at +92-333-855-4884 or email purchaseprocurement58@gmail.com. Submission deadline and detailed evaluation criteria are provided in the accompanying bid data sheet and instructions to bidders sections.
For Bidders: Our Analysis PAKISTANTENDER INSIGHT
Independent analysis by PakistanTender — not part of the official notice. Always confirm details against the original tender document.
This is a design-build contract for extension of a vaccine production facility at a major national health institute.
The scope involves design, construction, and supply of specialized vaccine filling and supply line equipment—a complex, specialized undertaking requiring pharmaceutical sector expertise and demonstrated capability in similar projects. The single-stage two-envelope process and integrity pact suggest a competitive, formally-managed procurement. The timeline to 24 September 2026 is standard. This is a one-off capital project rather than recurring services, suited to contractors with prior experience in pharmaceutical manufacturing facility expansion.
Who can bid: Typically required: PEC registration (Category F or higher for design-build work), valid NTN and SECP registration, evidence of past experience with vaccine or pharmaceutical facility projects, technical capability statement, and financial stability documentation. The notice requires bid security declaration and integrity pact compliance. No overt exclusions are stated, but pharmaceutical manufacturing experience is clearly essential.